Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 20.60
+0.15 (0.73%)
Oct 29, 2025, 1:09 PM CET
Fagron NV Employees
Fagron NV had 3,828 employees as of December 31, 2024. The number of employees increased by 483 or 14.44% compared to the previous year.
Employees
3,828
Change (1Y)
483
Growth (1Y)
14.44%
Revenue / Employee
€230,321
Profits / Employee
€21,481
Market Cap
1.50B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,828 | 483 | 14.44% |
| Dec 31, 2023 | 3,345 | 310 | 10.21% |
| Dec 31, 2022 | 3,035 | 189 | 6.64% |
| Dec 31, 2021 | 2,846 | 134 | 4.94% |
| Dec 31, 2020 | 2,712 | 97 | 3.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,378 |
| Ion Beam Applications | 2,287 |
| argenx SE | 1,599 |
| Nyxoah | 184 |
| European Medical Solutions | 122 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 49 |
| Sequana Medical NV | 48 |
Fagron NV News
- 19 days ago - Fagron NV (ARSUF) Q3 2025 Sales Call Transcript - Seeking Alpha
- 20 days ago - Fagron NV (ARSUF) Q3 2025 Sales/ Trading Statement Call - Slideshow - Seeking Alpha
- 20 days ago - Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook - GlobeNewsWire
- 5 months ago - Fagron increases share capital through exercise subscription rights - GlobeNewsWire
- 6 months ago - Fagron: Recent Capital Markets Day Confirms Upside Potential - Seeking Alpha
- 7 months ago - Record first-quarter revenue of €239 million, reflecting 14% topline growth - GlobeNewsWire
- 10 months ago - Fagron: FDA Warning Letter Creates New Entry Opportunity - Seeking Alpha
- 1 year ago - Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook - GlobeNewsWire